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Abstract 
The management of carotid artery disease includes both modifications in life style as well treatment of 
vascular risk factors. However, strict risk factor modification, including improved antihypertensive therapy, 
lipid management, smoking cessation, and antiplatelet therapy, promise for reducing the vascular event rate 
in patients with carotid atherosclerosis. The best medical management for stroke prevention was highlighted 
in clinical practice guidelines issued jointly in 2006 by the American Heart Association and the American 
Stroke Association, and co-sponsored by the Council on Cardiovascular Radiology and Intervention and the 
American Academy of Neurology. Lowering blood pressure to a target below 120/80 mm Hg by life style 
interventions and antihypertensive treatment. Glucose control to near-normoglycemic levels (target 
hemoglobin A1C ≤7%) is recommended among diabetics to reduce micro-vascular complications and, with 
lesser certainty, macrovascular complications. The primary objective of this review is to summarize the 
current evidence and standards for the advanced diagnostic and management strategies used in 
asymptomatic and symptomatic patients with carotid atherosclerosis. 
 
